Digital Ally Announces New Safety Product Releases In Response to Covid-19 Pandemic
Digital Ally (NASDAQ: DGLY) has launched two product lines in response to heightened safety measures due to the Covid-19 pandemic. The ThermoVu™ is a non-contact thermometer that facilitates temperature screening and access control in public venues. It features facial recognition and immediate feedback on temperature readings. Additionally, the company introduced Shield™, an EPA Category IV disinfectant and sanitizer, safe for use without protective gear. Both innovations aim to meet public health needs while ensuring compliance with regulations.
- Launch of ThermoVu™ enhances facility security with temperature-based entry control.
- Introduction of Shield™ meets demand for less harsh disinfectants amid Covid-19.
- ThermoVu™ features include facial recognition and instant alerts for temperature screening.
- Uncertain effectiveness of Shield™ against Covid-19 raises concerns.
- Potential supply chain disruptions may affect product distribution and profitability.
Non-contact thermometer/controlled-entry and EPA Category IV disinfectant/sanitizer among safety products introduced and marketed in second quarter under Company’s Shield™ and ThermoVu™ brands
Lenexa, KS, June 02, 2020 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY), which develops, manufactures and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and security, today announced the launch of two product lines in direct response to the increased safety precautions organizations and individuals are taking due to the Covid-19 pandemic.
ThermoVu™ is a non-contact temperature-measuring instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters. ThermoVu™ has optional features such as facial recognition to improve facility security by restricting access based on temperature and/or facial recognition reasons. ThermoVu™ provides an instant pass/fail audible tone with its temperature display and controls access to facilities based on such results. It can be widely applied in schools, office buildings, subway stations, airports and other public venues.
“We applied our years of experience with the latest cutting-edge sensor technology, real-time embedded electronics and video AI analytics in vetting and choosing the ThermoVu™ technology as the most powerful combination of fast, accurate, reliable and user friendly,” said Stan Ross, CEO of Digital Ally.
Digital Ally is launching its Shield™ Disinfectant/Sanitizer and several related products to fulfill demand by current customers and others for a disinfectant and sanitizer that is less harsh than many of the traditional products now widely distributed. The Shield™ product contains a powerful and effective cleaner with no harsh chemicals or fumes.
Hypochlorous Acid (HOCl), the active ingredient of Shield™ products, falls under EPA category IV, the safest of the EPA’s toxicity categories. While highly effective as a disinfectant and sanitizer, cleaning crews are not required to wear Personal Protective Equipment (PPE) when applying and reapplying HOCl.
“We’re humbled by the responsibility we’ve always had to provide safer alternatives to the public than what have been historically available,” said Ross, adding, “Our experience working for the mission critical law enforcement market and under stringent regulations at all levels position us to provide our customers with the non-contact temperature screening system and disinfectant that meet and exceed all relevant government regulations and guidelines.
About Digital Ally
Digital Ally®, headquartered in Lenexa, KS, specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security. Digital Ally’s complete product solutions include vehicle and body cameras, flexible software storage, automatic recording technology and various critical safety products. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.
For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here:
Facebook I Instagram I Linkedin I Twitter
Contact Information
Stanton Ross, CEO
Tom Heckman, CFO
Digital Ally, Inc
913-814-7774
info@digitalallyinc.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: whether the Company will be able to improve its revenue and operating results, especially in light of the adverse effects of the Covid-19 pandemic on its customers, suppliers and employees; whether the Company will effectively manage the disruptions to its supply chain and business activities caused by the Covid-19 pandemic; whether the Company will be able to effectively market and distribute the Shield™ and ThermoVu™ product lines to its customers; whether the Company can acquire Shield™ and ThermoVu™ products in the quantities and on a timely basis to fulfill its customers’ orders; whether the Company will be able to distribute the Shield™ and ThermoVu™ products in a cost-effective, profitable manner; whether Shield™ products will be proven effective against the Covid-19 virus as claimed by its manufacturer; whether the ThermoVu™ product will perform as anticipated; whether the Company’s new products will meet applicable government regulations as promulgated; whether the Company will be able to adapt its technology and products to new and different uses, including being able to introduce new products; competition from larger, more established companies with far greater economic and human resources; its ability to attract and retain customers and quality employees; the effect of changing economic conditions; and changes in government regulations, tax rates and similar matters and whether the Company will be successful in its patent infringement litigation with Axon Enterprises, Inc. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in its annual report on Form 10-K for the year ended December 31, 2019, and its Quarterly Report on Form 10-Q for the three months ended March 31, 2020 as filed with the Securities and Exchange Commission.
FAQ
What are the new products launched by Digital Ally under DGLY?
How does ThermoVu™ work for temperature screening?
What is the active ingredient in Shield™ disinfectant?
Why did Digital Ally launch these products?
What are the potential risks associated with these new products from DGLY?
